Roivant Sciences Ltd. (ROIV)
USD 11.69
(-3.79%)
USD 11.69
(-3.79%)
| Breakdown | 2024 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | 124.79 Million | 124.79 Million | 61.28 Million | 55.28 Million | 23.79 Million | 67.68 Million |
| Cost of Revenue | 15.56 Million | 15.56 Million | 13.12 Million | 8.96 Million | 2.05 Million | 1.13 Million |
| Gross Profit | 109.23 Million | 109.23 Million | 48.15 Million | 46.32 Million | 21.73 Million | 66.55 Million |
| Operating Expenses | -4.13 Billion | 1.18 Billion | 1.22 Billion | 1.39 Billion | 1.09 Billion | 598.98 Million |
| Selling, General and Administrative Expenses | 675.03 Million | 687.44 Million | 600.5 Million | 775.03 Million | 259.87 Million | 335.76 Million |
| Research and Development Expenses | 501.73 Million | 501.73 Million | 525.21 Million | 483.03 Million | 236.62 Million | 263.21 Million |
| Other Expenses | -5.3 Billion | -85.03 Million | 97.74 Million | 139.89 Million | 596.13 Million | - |
| Cost and Expenses | -4.11 Billion | 1.2 Billion | 1.23 Billion | 1.4 Billion | 1.09 Billion | 600.11 Million |
| Operating Income | 4.24 Billion | 4.24 Billion | -1.17 Billion | -1.35 Billion | -1.07 Billion | -532.42 Million |
| Interest Expense | 34.77 Million | 34.77 Million | 27.96 Million | 7.04 Million | 2.8 Million | 7.68 Million |
| Income Tax Expense | 22.22 Million | 22.22 Million | 5.19 Million | 369 Thousand | 1.68 Million | 7.12 Million |
| Earnings before Tax | 4.25 Billion | 4.25 Billion | -1.22 Billion | -923.74 Million | -898.54 Million | -560.98 Million |
| Net Income | 4.34 Billion | 4.34 Billion | -1 Billion | -845.26 Million | -809.23 Million | 1.2 Billion |
| Earnings Per Share Basic | 5.55 | 5.55 | -1.42 | -1.26 | -1.18 | 5.21 |
| Earnings Per Share Diluted | 5.23 | 5.23 | -1.42 | -1.26 | -1.18 | 5.21 |
| Weighted Average Shares Outstanding | 783.24 Million | 783.24 Million | 712.79 Million | 669.75 Million | 684.78 Million | 215.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 831.04 Million | 831.04 Million | 712.79 Million | 669.75 Million | 684.78 Million | 215.35 Million |
| Gross Margin | 0.88 | 0.88 | 0.79 | 0.84 | 0.91 | 0.98 |
| EBIT Margin | 34.54 | -7.99 | -19.22 | -16.58 | -37.64 | -8.17 |
| Profit Margin | 34.85 | 34.85 | -16.47 | -15.29 | -34.01 | 17.74 |
| EBITDA | 4.31 Billion | -996.51 Million | -1.17 Billion | -916.7 Million | -895.73 Million | -553.3 Million |
| Earnings Before Tax Margin | 33.99 | 33.99 | -19.18 | -24.45 | -45.01 | -7.87 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 124.79 Million | 28.93 Million | 37.14 Million | 37.1 Million | 21.62 Million | 61.28 Million |
| Cost of Revenue | 15.56 Million | 4.41 Million | 3.66 Million | 3.26 Million | 4.21 Million | 13.12 Million |
| Gross Profit | 109.23 Million | 24.51 Million | 33.47 Million | 33.83 Million | 17.41 Million | 48.15 Million |
| Operating Expenses | 1.18 Billion | 290.51 Million | 320.99 Million | 296.33 Million | 281.32 Million | 1.12 Billion |
| Selling, General and Administrative Expenses | - | 169.61 Million | 197.28 Million | 164.35 Million | 156.19 Million | - |
| Research and Development Expenses | - | 120.9 Million | 123.71 Million | 131.98 Million | 125.13 Million | - |
| Other Expenses | -85.03 Million | -33.06 Million | 25.41 Million | -27.46 Million | -49.91 Million | -62.19 Million |
| Cost and Expenses | 1.2 Billion | 294.93 Million | 324.66 Million | 299.6 Million | 285.53 Million | 1.13 Billion |
| Operating Income | 4.24 Billion | -266 Million | 5.06 Billion | 276.45 Million | -276.41 Million | -1.07 Billion |
| Interest Expense | 34.77 Million | 7.17 Million | 9.44 Million | 9.24 Million | 8.91 Million | 27.96 Million |
| Income Tax Expense | 22.22 Million | -8.95 Million | 25.67 Million | 3.75 Million | 1.75 Million | 5.19 Million |
| Earnings before Tax | 4.25 Billion | -191.45 Million | 5.09 Billion | -327.36 Million | -326.09 Million | -1.22 Billion |
| Net Income | 4.34 Billion | -151.11 Million | 5.09 Billion | -304.32 Million | -291.81 Million | -1.23 Billion |
| Earnings Per Share Basic | - | -0.19 | 6.37 | -0.40 | -0.38 | - |
| Earnings Per Share Diluted | - | -0.19 | 6.03 | -0.40 | -0.38 | - |
| Weighted Average Shares Outstanding | 783.24 Million | 802.85 Million | 800.58 Million | 770.22 Million | 759.27 Million | 712.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 831.04 Million | 802.85 Million | 844.46 Million | 770.22 Million | 759.27 Million | 712.79 Million |
| Gross Margin | 0.88 | 0.85 | 0.90 | 0.91 | 0.81 | 0.79 |
| EBIT Margin | - | -7.27 | -6.05 | -7.28 | -13.47 | - |
| Profit Margin | 34.85 | -5.22 | 137.22 | -8.20 | -13.50 | -20.07 |
| EBITDA | - | -210.37 Million | -224.77 Million | -270.08 Million | -291.27 Million | - |
| Earnings Before Tax Margin | 33.99 | -9.19 | 136.27 | 7.45 | -12.78 | -17.58 |
1942
ORPB
EVGN
ACHR
3796
CACC